Journal
Gynecologic Oncology Reports
Publication Date
2017
Volume
22
Inclusive Pages
48-51
Document Type
Open Access Publication
DOI
10.1016/j.gore.2017.09.003
Rights and Permissions
Zamorano AS, Wan L, Powell MA, Massad LS (2017) Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits. Gynecologic Oncology Reports, 22:48-51. https://doi.org/10.1016/j.gore.2017.09.003 © 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
Recommended Citation
Zamorano, Abigail S.; Wan, Leping; Powell, Matthew A.; and Massad, L. Stewart, "Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits." Gynecologic Oncology Reports. 22, 48-51. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6254
